Reduces the polarization of M2 GAMs and levels of VEGF, TGF-β1, and IL-6 by decreasing expression of Sox2, PDCD4, and STAT3, which inhibits GBM tumorigenesis. This evidence concerns the gene IL6 and glioblastoma.